Louisiana 2017 Regular Session

Louisiana House Bill HB436

Introduced
3/31/17  
Introduced
3/31/17  
Refer
3/31/17  
Refer
3/31/17  
Refer
4/10/17  
Refer
4/10/17  
Report Pass
5/10/17  
Refer
5/11/17  
Refer
5/11/17  
Engrossed
5/25/17  
Engrossed
5/25/17  
Refer
5/30/17  
Report Pass
5/31/17  
Report Pass
5/31/17  
Enrolled
6/4/17  
Enrolled
6/4/17  
Chaptered
6/14/17  
Chaptered
6/14/17  
Passed
6/14/17  

Caption

Requires drug manufacturers to provide information regarding prescription drug prices (EN NO IMPACT See Note)

Companion Bills

No companion bills found.

Previously Filed As

LA HB616

Provides for disclosure of prescription drug cost information

LA HB384

Creates and provides for a state prescription drug importation program (OR INCREASE SG EX See Note)

LA SB59

Provides relative to prescription drug price information. (gov sig)

LA SB282

Provides relative to prescription drug pricing. (8/1/18) (EN NO IMPACT See Note)

LA SF328

Manufacturers requirement to report and maintain prescription drug prices

LA SB00138

An Act Requiring Manufacturers Of Brand Name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

LA SB00262

An Act Requiring Manufacturers Of Brand Name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

LA SB00048

An Act Requiring Manufacturers Of Brand Name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

LA H1509

Prescription Drugs

LA SB00188

An Act Requiring Brand Name Prescription Drug Manufacturers To Provide Samples Of Brand Name Drugs To Generic Prescription Drug Manufacturers.

Similar Bills

No similar bills found.